Dominant regulation -: A common mechanism of monoclonal antibody induced tolerance?

被引:8
作者
Honey, K [1 ]
Cobbold, SP [1 ]
Waldmann, H [1 ]
机构
[1] Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 3RE, England
关键词
dominant tolerance; monoclonal antibodies; antigen presenting cell; infectious tolerance; linked suppression; transplantation;
D O I
10.1007/BF02786503
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Transplantation tolerance can be induced by a range of agents that block T cell/antigen-presenting cell (APC) interactions known to be important for initiation of the adaptive immune response. Tolerance so induced has been shown to have a regulatory phenotype dependent on CD4(+) cells. This was first observed with nonlytic anti-CD4 antibodies, and was recently demonstrated following other therapeutic approaches. Dominant tolerance also plays a role in natural regulation of the immune response, functioning to prevent autoaggressive cells mediating self-destruction. The mechanism by which dominant tolerance is established and maintained remains unclear, and the reported characteristics of regulatory cells in different experimental models vary widely. Here we review the evidence for potential mechanisms involved and propose that there is a common pathway by which dominant tolerance is mediated.
引用
收藏
页码:1 / 14
页数:14
相关论文
共 97 条
[1]   LONG-LIFE SPAN OF TOLERANT T-CELLS AND THE ROLE OF ANTIGEN IN MAINTENANCE OF PERIPHERAL TOLERANCE [J].
ALFERINK, J ;
SCHITTEK, B ;
SCHONRICH, G ;
HAMMERLING, GJ ;
ARNOLD, B .
INTERNATIONAL IMMUNOLOGY, 1995, 7 (02) :331-336
[2]   ANTI-CD4 MEDIATES CLONAL ANERGY DURING TRANSPLANTATION TOLERANCE INDUCTION [J].
ALTERS, SE ;
SHIZURU, JA ;
ACKERMAN, J ;
GROSSMAN, D ;
SEYDEL, KB ;
FATHMAN, CG .
JOURNAL OF EXPERIMENTAL MEDICINE, 1991, 173 (02) :491-494
[3]   A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function [J].
Anderson, DM ;
Maraskovsky, E ;
Billingsley, WL ;
Dougall, WC ;
Tometsko, ME ;
Roux, ER ;
Teepe, MC ;
DuBose, RF ;
Cosman, D ;
Galibert, L .
NATURE, 1997, 390 (6656) :175-179
[4]  
ARNOLD B, 1991, ANNU REV IMMUNOL, V9, P297, DOI 10.1146/annurev.iy.09.040191.001501
[5]   ANTI-IL-10 TREATMENT DOES NOT BLOCK EITHER THE INDUCTION OR THE MAINTENANCE OF ORALLY INDUCED TOLERANCE TO OVA [J].
AROEIRA, LS ;
CARDILLO, F ;
DEALBUQUERQUE, DA ;
VAZ, NM ;
MENGEL, J .
SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 1995, 41 (04) :319-323
[6]   Nasal administration of myelin basic protein prevents relapsing experimental autoimmune encephalomyelitis in DA rats by activating regulatory cells expressing IL-4 and TGF-beta mRNA [J].
Bai, XF ;
Shi, FD ;
Xiao, BG ;
Li, HL ;
vanderMeide, PH ;
Link, H .
JOURNAL OF NEUROIMMUNOLOGY, 1997, 80 (1-2) :65-75
[7]  
Bemelman F, 1998, J IMMUNOL, V160, P2645
[8]   Help for cytotoxic-T-cell responses is mediated by CD40 signalling [J].
Bennett, SRM ;
Carbone, FR ;
Karamalis, F ;
Flavell, RA ;
Miller, JFAP ;
Heath, WR .
NATURE, 1998, 393 (6684) :478-480
[9]   The effects of nondepleting CD4 targeted therapy in presensitized rat recipients of cardiac allografts [J].
Binder, J ;
Lehmann, M ;
Graser, E ;
Hancock, WW ;
Watschinger, B ;
Onodera, K ;
Sayegh, MH ;
Volk, HD ;
KupiecWeglinski, JW .
TRANSPLANTATION, 1996, 61 (05) :804-811
[10]  
Bluestone JA, 1997, J IMMUNOL, V158, P1989